Global High Throughput Screening (HTS) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global High Throughput Screening (HTS) Market Research Report 2024
According to MRAResearch’s new survey, global High Throughput Screening (HTS) market is projected to reach US$ 23230 million in 2033, increasing from US$ 15570 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole High Throughput Screening (HTS) market research.
Key companies engaged in the High Throughput Screening (HTS) industry include Agilent Technologies, Inc., Danaher Corporation, Thermofisher Scientific, Inc., PerkinElmer, Inc., Tecan Group Ltd., Merck Millipore, Bio-Rad Laboratories, Hamilton Company and Axxam S.p.A., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of High Throughput Screening (HTS) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole High Throughput Screening (HTS) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global High Throughput Screening (HTS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Agilent Technologies, Inc.
Danaher Corporation
Thermofisher Scientific, Inc.
PerkinElmer, Inc.
Tecan Group Ltd.
Merck Millipore
Bio-Rad Laboratories
Hamilton Company
Axxam S.p.A.
Aurora Biomed
Segment by Type
Cell-based Assays
3D - Cell Cultures
Ultra High Throughput Screening
Drug Discovery Programs
Chemical Biology Programs
Biochemical Screening
Cell- & Organ-based Screening
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The High Throughput Screening (HTS) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Key companies engaged in the High Throughput Screening (HTS) industry include Agilent Technologies, Inc., Danaher Corporation, Thermofisher Scientific, Inc., PerkinElmer, Inc., Tecan Group Ltd., Merck Millipore, Bio-Rad Laboratories, Hamilton Company and Axxam S.p.A., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of High Throughput Screening (HTS) were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole High Throughput Screening (HTS) market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global High Throughput Screening (HTS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Agilent Technologies, Inc.
Danaher Corporation
Thermofisher Scientific, Inc.
PerkinElmer, Inc.
Tecan Group Ltd.
Merck Millipore
Bio-Rad Laboratories
Hamilton Company
Axxam S.p.A.
Aurora Biomed
Segment by Type
Cell-based Assays
3D - Cell Cultures
Ultra High Throughput Screening
Segment by Application
Drug Discovery Programs
Chemical Biology Programs
Biochemical Screening
Cell- & Organ-based Screening
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The High Throughput Screening (HTS) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source